メニュー
Request a Quote
お問い合わせ
JP
future-of-immunotherapy-with-base-editing-literature-review1920x640
Webinar

Advancing gene editing efficiency and precision with the Pin-point™ Base Editing Platform

Gene editing is a critical capability, particularly in the fast-growing field of cell and gene therapy. However, scientists must take care that their gene edits do not result in unintended consequences. Technologies like CRISPR-Cas9 can generate multiplex edits, but the required multiple double strand breaks in the host cell genome may lead to cell toxicity, off-target editing, and unwanted genomic rearrangements.

Watch this on-demand webinar to learn how base editing with the novel Pin-point™ platform can achieve efficient and precise complex multiplex edits of cell lines, while decreasing the potential of unintended consequences.

In this webinar, you will learn:

  • How to achieve gene editing across multiple cell lines with improved precision.
  • What the critical considerations are for base editing of cell lines.
  • Why the Pin-point platform is highly effective at targeting multiple genes of interest simultaneously.
  • How Revvity’s Preclinical Services team use the Pin-point platform in a high-throughput workflow.

The Pin-point platform technology is available for clinical study and commercialization under a commercial license from Revvity. Pin-point reagents are available for research use only.

To view the full content please answer a few questions

By submitting my personal data, I acknowledge that Revvity Inc. and its affiliates (“Company”) will process my personal data provided above consistent with the Company’s Privacy Policy available here.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.